Search

everythinglearnresearchcommunity

for

Search:↓

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

PRP shows promise for treating hair loss but needs more research.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

ViviScal®, a food supplement, was found to be highly effective in treating hereditary hair loss in young males, while fish extract showed no impact.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride side effects in young men may be linked to specific gene variations.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Men with early-onset hair loss have more heart disease risk factors.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

miR-133b promotes hair growth and could be a potential treatment for hair loss.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.